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ABSTRACT
Lipases are commonly applied in the pharmaceutical and chemical industry, especially in immobilized 
form. The use of immobilized lipases facilitates the design of reactors and control of reactions, for exam-
ple, fast stopping the reaction. The immobilization procedure should increase the stability of the lipase 
and its activity, as well as be simple and efficient. Lipase B from Candida antarctica (CAL-B) is an enzyme 
from the lipase group, isolated from the Candida antarctica species. CAL-B has the highest activity in 
non-polar organic solvents, such as hexane and toluene, and the lowest in polar solvents, e.g. acetonitrile. 
Due to its hydrolytic properties, this enzyme degrades triglycerides of fatty acids to free fatty acids (FFA) 
and glycerol. Described lipase is often immobilized, in the aim to increase enantioselective and lipolytic 
activity. The kinetic and dynamic resolution with the application of lipase is one of the ways in obtaining 
an enantiopure form of the drugs, which usually are more effective and safer for the patient. The CAL-B 
could be also applied in the kinetic resolution of compounds being building blocks, derivates of drugs or 
conjugated forms. Furthermore, the CAL-B is used in the reactions in receiving of organic compounds, 
which are the natural origin, especially vegetable. Based on the presented data, it can be concluded, that 
CAL-B is an enzyme with a wide application in the biosynthesis of compounds with therapeutic activity.
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Introduction
Lipases (EC 3.1.1.3) are enzymes belonging to 
hydrolases (a subclass of esterases), catalyzing lip-
olysis, i.e. hydrolysis reaction of triacylglycerols (TAG). 
These molecules perform on the water-lipid interface. 
The widely used substrates for lipases are triglycerides 
(TAGs) - esters of glycerol and free fatty acids as well as 
phospholipids. Due to the possibility of using lipases in 
the synthesis or hydrolysis of many esters and amides, 
they are commonly applied in the pharmaceutical and 
chemical industry. From a medical point of view, these 
enzymes play a significant role in the metabolism of 
fatty acids in biological organisms. Most lipases are 
characterized by regioselectivity and stereospecificity 
towards specific functional groups of organic com-
pounds, hence they are used to catalyze a number of 
reactions to obtain substances for use in pharmacy 
[1–2]. In order to improve the efficiency of biocatalysis, 
the process of enzyme immobilization onto supports 
is carried out. Immobilization gives the possibility to 
modify the catalytic activity of tested enzymes. The 
mechanism of the immobilization process is based on 
intermolecular interactions between the enzyme protein 
and the appropriate functional group of the carrier. The 
aim of the process is increasing the enzymatic activity 
and technological stability as well as facilitating the 
reaction control. Other benefits of the process are the 
easier recovery of the biocatalyst, greater thermal stabil-
ity, and a wider range of activity in relation to molecular 
structures of substrates [3–5].
Lipase hydrolytic activity refers to the lipolysis re-
action in which the triglycerides are degraded in the 
presence of water. It should be emphasized that the 
phenomenon called interfacial activation of lipases and 
associated with it increase of enzyme activity is widely 
described in the literature [6]. Moreover, in literature, 
there were also presented characteristic elements of 
the molecular structure of lipases (among others, the 
lid domain) allowing to control the substrate exposition 
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to the active centre of the enzyme. In consequence, 
in a lipid-water phase, there may be a change in the 
conformation of the enzyme (open and close form).
Lipase B from Candida antarctica 
(CAL-B) 
Characteristic
CAL-B is an enzyme from the lipase group, isolated 
from the Candida antarctica species. In terms of biochem-
istry, it belongs to the group of hydrolases containing the 
catalytic triad. Unlike other lipases, most CAL-B surfaces 
are naturally hydrophobic. The native form of CAL-B 
is active in the pH range from 6–10, and its isoelectric 
point is 6.8. CAL-B has the highest activity in non-polar 
organic solvents, such as hexane and toluene, and the 
lowest in polar solvents, e.g. acetonitrile. It has not been 
proven that CAL-B lipase shows interfacial activation to 
a large extent, despite the high catalytic activity. This may 
be due to the lack of the “lid” domain, and this could 
influence the regulation of substrate access to the active 
centre. In respect of the molecular structure, the a-5 and 
the a-10 helices are the most mobile parts of the lipase 
structure. Molecular simulations show the movement 
of the a-5 helix in the direction of the a-10 helix, which 
underlines the key role of the a-5 helix in the formation 
of CAL-B interaction with the hydrophobic surface. The 
a-5 helix behaves like a “lid” [6]. It is believed that the 
open and closed structure of CAL-B is not only related to 
interfacial activation but also have an effect on the lipase 
catalytic properties. Despite the enormous progress in 
understanding and controlling the catalytic activity of 
CAL-B, the presence of the “lid” structure is discussed, 
and there is a lack of solid evidence regarding the in-
terfacial activation of this enzyme. Due to its hydrolytic 
properties, this enzyme degrades triglycerides of fatty 
acids to free fatty acids (FFA) and glycerol. The reaction 
is reversible. In view of the high enantioselectivity, thermal 
stability and stability in organic solvents, this enzyme is 
one of the most widely used lipases in biocatalysis [7–8]. 
The structure of CAL-B is shown in Figure 1.
Immobilization of lipase
The use of catalysts such as lipases in many cases 
requires their recovery and reuse for economic and 
environmental reasons. The use of immobilized lipases 
facilitates the design of reactors and control of reactions, 
for example, fast stopping the reaction. Immobilization 
of lipases is often performed when biocatalysts are used 
in industrial scale. This procedure should increase the 
stability of the lipase and its activity, as well as be simple 
and efficient [11].  
Figure 1. The crystalline structure of lipase B from Candida 
antarctica [9–10]
Techniques of immobilization of lipases
Many materials, including various polymer resins, 
cellulose polymers, silica, ceramics, carbon nanotubes, 
magnetic particles, and microspheres, have been tested 
for the immobilization of lipases.
Techniques of immobilization of lipases can be 
divided into four types [12]:
1) physical adsorption; 
2) chemical bonding (covalent or ionic);
3) cross-linking;
4) entrapment.
Depending on the type of interaction between the 
carrier and the enzyme, these techniques were divided 
into reversible and irreversible. In the case of the irre-
versible methods, lipase cannot be disconnected from 
the support without destroying its biological activity or 
carrier. On the other hand, in the reversible methods, the 
lipase can be separated from the carrier under mild con-
ditions. Covalent bonding, entrapment and cross-linking 
are the most commonly used procedures of irreversible 
immobilization of lipases. Physical adsorption and 
various non-covalent bonds such as chelation are 
well-known procedures for reversible immobilization.
Lipase B from Candida antarctica 
(CAL-B) — application
Drug synthesis
CAL-B is widely applied as a biocatalyst in biochem-
ical and pharmaceutical reactions. This enzyme is often 
immobilized, in the aim of increasing its enantioselective 
and lipolytic activity. The immobilized form usually has 
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a better ability to kinetic or dynamic kinetic resolution 
of a racemic mixture of enantiomers of pharmaceutical 
compounds. Due to enantiomers are characterized by 
a different pharmacodynamical profile, it is important 
to effectively separate each enantiomer from race-
mic mixtures. The kinetic and dynamic resolution is 
performed in order to obtain an enantiopure form of 
drugs, which usually are more effective and safer for 
the patient. An example of the application of lipases as 
a biocatalyst is the kinetic resolution of (R,S)-ibuprofen 
or (R,S)-flurbiprofen, and other drugs from the profen 
group. (R)-ibuprofen enhanced the side effects of the 
racemic drug on, among others, gastrointestinal and 
renal tract, hence it is desirable to use only the (S)-en-
antiomer. Henke et al. applied the CAL-B in the kinetic 
resolution of (R,S)-ibuprofen and the vinyl esters with 
high optically pure were obtained [13]. Regarding 
flurbiprofen, (R)-enantiomer is inactive on both forms 
of cyclooxygenase but has antinociceptive properties, 
and could have potential application in the treatment of 
prostate and colon cancer. Siódmiak et al. carried out 
the kinetic resolution of flurbiprofen, catalyzed by CAL-B 
immobilized onto the support (Novozym 435). Authors 
obtained the methyl ester of (R)-flurbiprofen with the 
high enantiomeric excess [14]. Another group of drugs 
achieved with the use of CAL-B is b-blockers, for exam-
ple, (R,S)-propranolol. The individual enantiomers of 
propranolol show differences in clinical and adverse 
effects. Barbosa et al. achieved optically pure vinyl es-
ters of propranolol in the reaction catalyzed by CAL-B 
immobilized on epoxide supports [15], whereas Sikora 
et al. performed the kinetic resolution of (R,S)-propran-
olol, catalyzed by native CAL-B in toluene in order to 
obtain (S)-propranolol acetate [16]. The CAL-B has 
applied also in the kinetic resolution of compounds 
being a building block in the synthesis of ticagrelor, one 
of the most important antithrombotic pharmaceutical 
compound. Wang et al. performed transesterification 
of azolide derivates (investigated for an application in 
ticagrelor synthesis) with methyl tert-butyl ether, cat-
alyzed by CAL-B, in the immobilized form (Novozym 
435). The reaction was enantioselective, the E value 
was 197 [17]. Recent publications reported about CAL-B 
application in biosynthesis of methotrexate, anticancer 
and antirheumatic drug, in conjugated form. Noro et al. 
performed the transesterification of acylglycerols and 
cyclodextrins conjugated with methotrexate, catalyzed 
by CAL-B immobilized onto polyacrylic support, in the 
presence of ultrasounds [18]. CAL-B was also used in 
the synthesis of azelaic acid derivates. Azelaic acid is 
widely applied in skin diseases as inflammatory acne. 
The derivates of the azelaic acid are characterized by 
better solubility and require less dosage than acid form. 
The synthesis by esterification of azelaic acid with lauryl 
alcohol, catalyzed by CAL-B (Novozym 435) was carried 
out by Khairudin et al. The high conversion (> 95%) was 
achieved with a small amount of enzyme [19].
Synthesis of natural origins compounds
The CAL-B is used in the reactions for receiving 
organic compounds, which are the natural origin, 
especially vegetable. One of the examples are com-
pounds from the flavonoid group applied as a natural 
antioxidant. The chemical structure of flavonoids show 
low solubility in non-aqueous solvents, hence, this 
form has limited application in the biotechnological 
and pharmaceutical industry. The problem could be 
solved by acylation of flavonoids. As a result of the 
reaction, the acylated flavonoid can penetrate into the 
skin and induce the antioxidative effect. Passicos et al. 
developed the one-step method of acylation of routine 
and naringenin, with the use of immobilized CAL-B 
(Novozym  435) as a catalyst. The methyl palmitate was 
the donor of the acyl group, and the primary hydroxyl 
group of sugar rest of naringenin and routine was an 
acceptor, whereas 2-methyl-2-butanol was the solvent. 
For naringenin, a good result was achieved — 92% used 
flavonoid in the reaction was acylated [20].
The similar method in obtaining of acylated fla-
vonoids was presented by Stevenson et al. In the 
case of isoquercitrin and naringenin, it achieved the 
significantly improve their hydrophobicity and better 
antioxidant effect. The acids: cinnamic, palmitate and 
phenylpropionic were the acyl group donor. The fla-
vonoids were extracted from the apple and blueberry 
fruit. CAL-B also showed the selective acylation towards 
the primary hydroxyl group of the sugar portion of the 
flavonoid [21].
It was proven, that the application of CAL-B in receiv-
ing of an oleic ester of quercetine by acylation reaction 
is reasonable to greatly improve lipophilicity. The study 
was described by Saik et al. [22], in which the reaction 
catalyzed by lipase of quercetine with oleic acid as an 
acyl donor group was carried out.
The transesterification reaction catalyzed by CAL-B 
was used also in obtaining compounds present in 
policosanol achieved from carminic acid production. 
Carminic acid is a natural dye, used in the food in-
dustry. Policosanol is a mixture of long-chain alcohol, 
found in various plant and animal origin products, with 
the antiatherosclerotic properties. Ramos-Zambrano 
et al. performed transesterification of policosanol from 
waxy waste with used of CAL-B (recombinant with 
Aspergillus niger) immobilized on polymeric support 
Immobead 150 as an efficient and eco-friendly method. 
A different acyl donor group were applied, the most 
catalytically efficient was a reaction with isopropanol 
as a donor. The mainly obtained compound was tria-
contanol [23].
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Conclusions
Lipase B from Candida antarctica is an enzyme with 
a wide application in the synthesis of compounds with 
therapeutic activity. Due to the possibility of immobili-
zation of this enzyme onto solid supports, its multiple 
reuses in reactions become possible. To date, well-doc-
umented studies of the use of CAL-B in the biosynthesis 
indicate that with properly optimized procedures, this 
enzyme is one of the most appropriate and effective 
solutions in obtaining organic compounds for the ap-
plication in medicine and pharmacy.
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